Oruka Therapeutics, Inc. · NASDAQ:ORKA
Sandler Laura Lee sold 5,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 1, 2026
On Sep 1, 2026, Sandler Laura Lee (Chief Operating Officer) sold 5,000 Oruka Therapeutics, Inc. shares at an average US$91.82 for US$459K under a trading plan, leaving 236,384 shares. Filed Sep 1, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$91.82 average (US$91.05 to US$92.01)
- Value
- US$459K
- Holding after
- 236,384 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Option exercise | 5,000 | US$7.80 | 241,384 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 1,000 | US$91.05 | 240,384 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 4,000 | US$92.01 | 236,384 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Sandler Laura Lee
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Sandler Laura Lee · Sep 15, 2026
- Form 4 · Sandler Laura Lee · Jul 1, 2026
- Form 4 · Sandler Laura Lee · Jun 15, 2026
- Form 4 · Sandler Laura Lee · May 1, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026